A Clinical Study to Assess the Efficacy & Safety of DA-3002

Updated 05/14/2024

Status Completed

Clinical Trial Summary

A study demonstrates the non-inferiority of DA-3002 when compared with Genotropin®.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01813630
Study type	Interventional
Source	Dong-A ST Co., Ltd.
Contact
Status	Completed
Phase	Phase 3
Start date	February 2013
Completion date	May 2018

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00006334` - Turner Syndrome: Genotype and Phenotype	N/A
	Not yet recruiting	`NCT02871986` - Pubertal Induction in Individuals With Hypogonadism	N/A
	Completed	`NCT01306357` - Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
	Completed	`NCT00001221` - Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome	Phase 2
	Completed	`NCT00250250` - An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG	Phase 3
	Completed	`NCT00004275` - Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome	Phase 2
	Completed	`NCT00001253` - The Effects of Estrogen on Cognition in Girls With Turner Syndrome	Phase 2
	Completed	`NCT00013546` - Hormone Replacement Therapy to Treat Turner Syndrome	Phase 2
	Terminated	`NCT02018172` - Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device	N/A
	Completed	`NCT01066052` - Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years	Phase 4
	Completed	`NCT00004274` - Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome	N/A
	Completed	`NCT00001343` - The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome	Phase 2
	Terminated	`NCT00870220` - Initiating Transdermal Estradiol Therapy in Turner's Syndrome	Phase 1